Recommendations on trichological treatments during COVID-19 pandemic

References

• Goren A, McCoy J, Wambier CG, et al. What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy. Dermatol Ther. 2020. DOI:https://doi.org/10.1111/dth.13365
   Google Scholar
• Mikkonen L, Pihlajamaa P, Sahu B, et al. Androgen receptor and androgen-dependent gene expression in lung. Mol Cell Endocrinol. 2010;317(1–2):14–24.
   PubMed Web of Science ®Google Scholar
• Murrell DF, Murase JE. The dermatologist’s perspective: why is COVID-19 mortality lower in females than males? Int J Womens Dermatol. 2020. DOI:https://doi.org/10.1016/j.ijwd.2020.04.011
   Google Scholar
• Alfredo R, Carmen C, Luca M, et al. Minoxidil use in dermatology, side effects and recent patents. Recent Patents on Inflam Allergy Drug Disc. 2012;6:130–136.
   PubMedGoogle Scholar
• Smeitink J, Jiang X, Pecheritysna S, et al. Hypothesis: mPGES-1-derived prostaglandin E2, a so far missing link in COVID-19 pathophysiology? Preprints 2020. DOI:https://doi.org/10.20944/preprints202004.0180.v1
   Google Scholar
• Clark RV, Hermann DJ, Cunningham GR, et al. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004;89(5):2179–2184.
   PubMed Web of Science ®Google Scholar
• Hoffmann R, Niiyama S, Huth A, et al. 17alpha-estradiol induces aromatase activity in intact human anagen hair follicles ex vivo. Exp Dermatol. 2002;11(4):376–380.
   PubMed Web of Science ®Google Scholar
• Suba Z. Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients. J Pharm Pharm Sci. 2020;23(1):75–85.
   PubMed Web of Science ®Google Scholar
• Li H, Chen C, Hu F, et al. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis. Leukemia. 2020;34(6):1503–1509.
   PubMed Web of Science ®Google Scholar
• Russell B, Moss C, Rigg A, et al. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? Ecancermedicalscience. 2020;14:1023.
   PubMed Web of Science ®Google Scholar
• Mikuls TR, Johnson SR, Fraenkel L. American College of Rheumatology guidance for the management of adult patients with rheumatic disease during the COVID-19 pandemic. Arthritis Rheumatol. 2020. DOI:https://doi.org/10.1002/art.41301
   Google Scholar
• Rossi A, Campo D, Fortuna MC, et al. A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia. J Dermatolog Treat. 2018;29(2):149–151.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhao Y, Zhang F, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the experience of clinical immunologists from China. Clin Immunol . 2020;214:108393.
   PubMed Web of Science ®Google Scholar
• Conforti C, Giuffrida R, Zalaudek I, et al. Doxycycline, a widely used antibiotic in dermatology with a possible anti‐inflammatory action against IL ‐6 in COVID ‐19 outbreak. Dermatologic Ther. 2020. DOI:https://doi.org/10.1111/dth.13437
   Google Scholar
• Diana G, Strollo R, Diana D, et al. Cardiac safety and potential efficacy: two reasons for considering minocycline in place of azithromycin in COVID-19 management. Euro Heart J - Cardiovasc Pharmacother. 2020. DOI:https://doi.org/10.1093/ehjcvp/pvaa049
   Google Scholar
• Gbinigie K, Frie K. Should azithromycin be used to treat COVID-19? A rapid review. BJGP Open. 2020. DOI:https://doi.org/10.3399/bjgpopen20X101094
   Google Scholar
• Ricardo JW, Lipner SR. Recommendations for treatment of nail lichen planus during the COVID-19 pandemic. Dermatol Ther. 2020 [cited 2020 May 10]; [e13551].
   PubMed Web of Science ®Google Scholar
• Wollina U, Gemmeke A, Koch A. Dissecting cellulitis of the scalp responding to intravenous tumor necrosis factor-alpha antagonist. J Clin Aesthet Dermatol. 2012;5(4):36–39.
   PubMedGoogle Scholar
• Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect. 2020;80(6):607–613.
   PubMed Web of Science ®Google Scholar
• Lebwohl M, Rivera-Oyola R, Murrell DF. Should biologics for psoriasis be interrupted in the era of COVID-19? J Am Acad Dermatol. 2020;82(5):1217–1218.
   PubMed Web of Science ®Google Scholar
• Pourang A, Mesinkovska NA. New and emerging therapies for alopecia areata. Drugs. 2020;80(7):635–646.
   PubMed Web of Science ®Google Scholar
• Stebbing J, Phelan A, Griffin I, et al. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis. 2020;20(4):400–402.
   PubMed Web of Science ®Google Scholar
• Favalli EG, Biggioggero M, Maioli G, et al. Baricitinib for COVID-19: a suitable treatment? Lancet Infect Dis. 2020. DOI:https://doi.org/10.1016/S1473-3099(20)30262-0
   PubMed Web of Science ®Google Scholar
• Grageda E. Platelet-rich plasma and bone graft materials: a review and a standardized research protocol. Implant Dent. 2004;13:301–309.
   PubMedGoogle Scholar
• Stevens J, Khetarpal S. Platelet-rich plasma for androgenetic alopecia: a review of the literature and proposed treatment protocol. Int J Womens Dermatol. 2019;5(1):46–51.
   PubMedGoogle Scholar
• Iuliano AD, Roguski KM, Chang HH, et al. Global seasonal influenza-associated mortality collaborator network. Lancet. 2018;391(10127):1285–1300.
   PubMed Web of Science ®Google Scholar
• Loffredo L, Martino F, Zicari AM, et al. Enhanced NOX-2 derived oxidative stress in offspring of patients with early myocardial infarction. Int J Cardiol. 2019;293:56–59.
   PubMed Web of Science ®Google Scholar
• Perrone LA, Belser JA, Wadford DA, et al. Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in mice. J Infect Dis. 2013;207(10):1576–1584.
   PubMed Web of Science ®Google Scholar
• Imai Y, Kuba K, Neely GG, et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133(2):235–249.
   PubMed Web of Science ®Google Scholar
• Wang J-Z, Zhang R-Y, Bai J. An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients. Int J Cardiol. 2020;312:137–138.
   PubMed Web of Science ®Google Scholar
• Hernández A, Papadakos PJ, Torres A, et al. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. Rev Esp Anestesiol Reanim. 2020;67(5):245–252.
   PubMed Web of Science ®Google Scholar
• Fowler AA, 3rd, Truwit JD, Hite RD, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA. 2019;322(13):1261–1270.
   PubMed Web of Science ®Google Scholar
• Carr AC. A new clinical trial to test high-dose vitamin C in patients with COVID-19. Crit Care. 2020;24(1):133.
   PubMed Web of Science ®Google Scholar
• Gade VKV, Mony A, Munisamy M, et al. An investigation of vitamin D status in alopecia areata. Clin Exp Med. 2018;18(4):577–584.
   PubMed Web of Science ®Google Scholar
• Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020;12(4):988.
   PubMed Web of Science ®Google Scholar
• Rossi A, Mari E, Scarno M, et al. Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study. Int J Immunopathol Pharmacol. 2012;25(4):1167–1173.
   PubMed Web of Science ®Google Scholar
• Yang N, Zhang H, Cai X, et al. Epigallocatechin-3-gallate inhibits inflammation and epithelial-mesenchymal transition through the PI3K/AKT pathway via upregulation of PTEN in asthma. Int J Mol Med. 2018;41:818–828.
   PubMed Web of Science ®Google Scholar
• Ling LJ, Lu Y, Zhang YY, et al. Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling. Phytomedicine. 2020;67:153150.
   PubMed Web of Science ®Google Scholar
• Messina G, Polito R, Monda V, et al. Functional role of dietary intervention to improve the outcome of COVID-19: a hypothesis of work. Int J Mol Sci. 2020;21(9):E3104.
   PubMed Web of Science ®Google Scholar
• Calder PC. n-3 Fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc Nutr Soc. 2013;72(3):326–336.
   PubMed Web of Science ®Google Scholar
• Jacob A, Wu R, Zhou M, et al. Mechanism of the anti-inflammatory effect of curcumin: PPAR-gamma activation. PPAR Res. 2007;2007:89369.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41(1):40–59.
   PubMed Web of Science ®Google Scholar
• Ciavarella C, Motta I, Valente S, et al. Pharmacological (or Synthetic) and nutritional agonists of PPAR-γ as candidates for cytokine storm modulation in COVID-19 disease. Molecules. 2020;25(9):2076.
   Web of Science ®Google Scholar
• Fischer TW, Burmeister G, Schmidt HW, et al. Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial. Br J Dermatol. 2004;150(2):341–345.
   PubMed Web of Science ®Google Scholar
• Fischer TW, Slominski A, Tobin DJ, et al. Melatonin and the hair follicle. J Pineal Res. 2008;44(1):1–15.
   PubMed Web of Science ®Google Scholar
• Shneider A, Kudriavtsev A, Vakhrusheva A. Can melatonin reduce the severity of COVID-19 pandemic? Int Rev Immunol. 2020;29:1–10.
   Web of Science ®Google Scholar
• Zhang R, Wang X, Ni L, et al. COVID-19: melatonin as a potential adjuvant treatment. Life Sci. 2020;250:117583.
   PubMed Web of Science ®Google Scholar